Trial: 201906102

A Biomarker-Driven Protocol For Previously Treated ALK-Positive Non-Squamous NSCLC Patients: The NCI-NRG ALK Master Protocol

Phase

II

Principal Investigator

Waqar, Saiama

Disease Site

Lung; Lung Cancer – Non-small Cell

Learn more about this study at: clinicaltrials.gov